SL

Samuel Lanyon

Lumos Diagnostics Holdings Limited | Non-Executive Chairman, Non-Executive Director
Mr Lanyon has more than 25 years of experience in strategy, sales and operations with a track record in the global commercialization of technology rich healthcare products. Mr. Lanyon currently serves as Executive Director and co-founder of Planet Innovation and a Non-Executive Director of Paragon Funds Management. He also serves as a Non-Executive Director of Visus Therapeutics, a clinical-stage company focused on developing innovation medicines to improve vision. Previously, Mr. Lanyon held international executive roles with Leica Microsystems, part of Danaher Corporation. He is a member of Member of the Disclosure Committee and risk committee.

Company and Roles

Company
Title
Tenure
Since
LDX
Lumos Diagnostics Holdings Limited
  • Non-Executive Chairman
  • Non-Executive Director
1yrs, 10mthJun 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
LDX
Lumos Diagnostics Holdings Limited
03/08/23N/A979,3672,246,500N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
LDX
Lumos Diagnostics Holdings Limited
03/08/23
Issued
285,714$0.070$20,000Participation in share purchase plan
LDX
Lumos Diagnostics Holdings Limited
30/11/22
Issued
113,934$0.232$26,426Issue of securities
LDX
Lumos Diagnostics Holdings Limited
30/11/22
Issued
2,246,500$0.049$110,078Issue of options
LDX
Lumos Diagnostics Holdings Limited
30/11/22
Expiry
163,302$0.049$8,001Options expired
LDX
Lumos Diagnostics Holdings Limited
30/06/22
Issued
163,302$0.140$22,862Issue of options